LRRK2-IN-8 - Search Results | AbMole BioScience

About 6 results found for searched term "LRRK2-IN-8" (0.128 seconds)

Cat.No.	Name	Target
M49509	LRRK2-IN-8	LRRK2
	LRRK2-IN-8 is a LRRK2 inhibitor.
M4831	GSK2578215A	LRRK2
	GSK2578215A is a potent and selective LRRK2 kinase inhibitor with IC50 of 8.9 nM and 10.9 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
M6649	CZC-25146	LRRK2
	CZC25146
	CZC 25146 is a potent and orally active LRRK2 inhibitor with IC50 values of 4.76 nM and 6.87 nM for wild-type LRRK2 and G2019S LRRK2, respectively. CZC-25146 inhibits PLK4, GAK, TNK1, CAMKK2 and PIP4K2C as well.
M8313	CZC-25146 hydrochloride	LRRK2
	CZC-25146 is a potent selective and metabolically stable inhibitor of leucine-rich repeat kinase-2 (LRRK2) also known as dardarin or PARK8, a kinase with mutations linked to Parkinson’s disease.
M20669	CZC-54252	LRRK2
	CZC-54252 is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for human wild type LRRK2 and G2019S LRRK2, respectively.
M58400	CZC-54252 hydrochloride	LRRK2
	CZC-54252 HCl
	CZC-54252 hydrochloride is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2, respectively.